Drug intelligence / Profile preview

idrocilamide

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Idrocilamide is a small molecule skeletal muscle relaxant and anti-inflammatory drug used primarily as a topical cream to treat lumbago and other types of muscular pain. It is available by prescription or over-the-counter in France and several other countries. Mechanistically, idrocilamide acts on the central nervous system by influencing motor neurons that control muscle activity. At the cellular level, it decreases sarcoplasmic reticulum calcium release within muscle fibers and facilitates voltage-dependent inactivation of the voltage sensor for excitation-contraction coupling externally. Additionally, it is a potent inhibitor of caffeine metabolism[1][4][5][6].

Brand names
TalvalSrilaneRelaxnovaBrolitène
Other names
N-(2-hydroxyethyl)cinnamamideN-(2-Hydroxyethyl)-3-phenyl-2-propenamideBrolitene
02

Targets

CYP1A2 (Cytochrome P450 1A2)

Beyond the preview

Go deeper on idrocilamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on idrocilamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call